<unk>  is a coticosteroid emollient that is FDA approved for the treatment of corticosteroid-responsive dermatoses in patients 12 years of age or older, severe plaque-type psoriasis in patients 16 years of age and older.   Common adverse reactions include pruritis,irritation, erythema, folliculitis, cracking and fissuring of the skin, numbness of the fingers, tenderness in the elbow, skin atrophy, and telangiectasia.
Clobetasol propionate
Halobetasol
Tretinoin 
Isotretinoin
Alitretinoin
Psoralen
Etretinate
Mometasone furoate